Will MDMA Be Approved?!?
The Psychiatry Tomorrow Podcast Weighs In
This newsletter is a daily, health-themed, and, as recently dubbed by one reader, “humor-adjacent” publication. Sometimes, I do guest appearances on podcasts. I enjoy this activity quite a bit. As it happens, in the center of the Venn diagram that depicts “activities that are likely to involve Owen Muir,” we have the overlap of “talking about psychedelics,” “a podcast,” and “
—yes, my wife—hosting a podcast.”She invited me, along with Andrew Penn and Boris Heifets, to have the following spirited discussion. We do some light pontificating about the unknown future of MDMA-AT’s NDA to the FDA. Then, there is substantial nerd-ing out about clinical trial design.
I hope my readers will enjoy the conversation! The podcast is one of the signature media properties from the team at Osmind—a learning health system.